| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 273 |
| 1 | MYCOPHENOLATE MOFETIL | 244 |
| 2 | METHOTREXATE SODIUM | 232 |
| 3 | DUPILUMAB | 230 |
| 4 | METHOTREXATE | 218 |
| 5 | RITUXIMAB | 212 |
| 6 | METHYLPREDNISOLONE | 208 |
| 7 | TACROLIMUS | 201 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 200 |
| 9 | TACROLIMUS OINTMENT 0.1% | 200 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE | 4 | 0.0645 |
| 1 | FROVATRIPTAN SUCCINATE | 42 | 0.0526 |
| 2 | CEFUROXIME SODIUM | 29 | 0.0237 |
| 3 | DANAZOL | 50 | 0.0176 |
| 4 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 3 | 0.0132 |
| 5 | NITAZOXANIDE | 4 | 0.0115 |
| 6 | L-TRYPTOPHAN | 5 | 0.0113 |
| 7 | DELGOCITINIB | 3 | 0.0112 |
| 8 | PIMOZIDE | 5 | 0.0104 |
| 9 | STIRIPENTOL | 21 | 0.0092 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 678 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 230 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 227 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 223 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 220 |
| 5 | Alkylating Drug [EPC] | 194 |
| 6 | Benzodiazepine [EPC] | 191 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 179 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 170 |
| 9 | Kinase Inhibitor [EPC] | 139 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 1 | Antileishmanial [EPC] | 5 | 0.0129 |
| 2 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 3 | Interleukin-36 Receptor Antagonist [EPC] | 3 | 0.0074 |
| 4 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 7 | 0.0056 |
| 6 | Interleukin-6 Antagonist [EPC] | 3 | 0.0046 |
| 7 | Human Immunoglobulin G [EPC] | 84 | 0.0040 |
| 8 | CD123 Interaction [EPC] | 2 | 0.0037 |
| 9 | Vasoconstrictor [EPC] | 1 | 0.0033 |